Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumours

Title: The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumours
Authors: Yilmaz, Bahiddin; Erdem, Dilek; Teker, Fatih; Goren, Ibrahim; Yildirim, Beytullah; Kut, Engin; Yucel, Idris
Contributors: OMÜ
Publisher Information: Sage Publications Ltd
Publication Year: 2016
Subject Terms: Hepatitis B virus reactivation; hepatitis B surface antibody; chemotherapy; solid tumour; haematological malignancy
Description: TEKER, FATIH/0000-0003-4693-6587 ; WOS: 000377346400021 ; PubMed: 27048386 ; Objective To investigate the effect of immunosuppressive anticancer therapy on titre levels of anti-hepatitis B surface antibodies (anti-HBs) in hepatitis B surface antigen (HBsAg) negative and anti-HBs positive patients with haematological malignancies or solid tumours. Methods This retrospective study reviewed the medical records of patients with haematological malignancies or solid tumours. Pretreatment HBsAg negative and anti-HBs positive patients were included in the analysis. Anti-hepatitis B core antibody status was used to evaluate vaccinated patients and those with resolved HBV infections. Results The medical records of 237 patients were reviewed retrospectively. The median anti-HBs titre decreased significantly after anticancer therapy compared with the pretreatment median anti-HBs titre in all patients (71mIU/ml versus 57mIU/ml). Anti-HBs titre decreased significantly in patients with haematological malignancies (70mIU/m versus 37mIU/ml) and in patients administered rituximab-based chemotherapy (67mIU/ml versus 33mIU/ml) following chemotherapy, whereas there was no significant change in patients with solid tumours. After chemotherapy, patients with low pretreatment anti-HBs titres (
Document Type: article in journal/newspaper
Language: English
Relation: Journal of International Medical Research; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.1177/0300060516638992; https://hdl.handle.net/20.500.12712/13324; 44; 627; 638
DOI: 10.1177/0300060516638992
Availability: https://hdl.handle.net/20.500.12712/13324; https://doi.org/10.1177/0300060516638992
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.C7E5ECBA
Database: BASE